Efficacy and Safety of Long-Term Treatment With the Combination of Amlodipine Besylate and Olmesartan Medoxomil in Patients With Hypertension
J Clin Hypertens (Greenwich). © 2009 Wiley Periodicals, Inc. The authors report on the 44-week open-label extension of the 8-week, double-blind Combination of Olmesartan Medoxomil and Amlodipine Besylate in Controlling High Blood Pressure (COACH) trial in 1684 patients. Initial therapy was amlodipine (AML) plus olmesartan medoxomil (OM) 5+40 mg/d, up-titrated to AML+OM 10+40 mg/d plus hydrochlorothiazide (HCTZ) 12.5 mg then 25 mg if patients did not achieve blood pressure (BP) goal ( (Source: The Journal of Clinical Hypertension)
Camp For Alzheimer's Patients Isn't About Memories
An unusual sleepover camp brings together about 20 people who have dementia for a weekend of music, dance, reminiscing and other activities that emphasize strengths instead of losses. While the campers typically won't remember details of the retreat, it lifts their mood, camp staffers say.raquo; E-Mail Thisnbsp;nbsp;nbsp;nbsp; raquo; Add to Del.icio.us (Source: NPR Health and Science)div id=medwormpbiMedWorm Message:/i/b Register forba href=http://www.medmatcha.com target =_selfMedMatcha, MedWorm's medical advertising network/a/b, and receive $5 free advertising./p/div
